Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/TRUL stock hub

CSE/TRUL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

CSE/TRULis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.3B
Canadian Securities Exchange
Market data

Live price

Current market quote for this ticker.

Current price
CSE/TRUL
In the news

Latest news · CSE/TRUL

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E109
P25 11P50 15.6P75 25.4
Trailing P/En/a
P25 7.4P50 15.6P75 34.3
ROE-6.9
P25 -121.5P50 -40.9P75 0.5
ROIC-8.7
P25 -72.5P50 -16P75 1.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All CSE/TRUL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
201
Groups with data
11
Currency
USD
Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Canada
Country code
CA
Employees
5,000
Employees Change
-1,000%
Employees Change Percent
-16.67
Enterprise value
CAD 2.7B
Exchange
Canadian Securities Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
CA89788C1041
Last refreshed
2026-05-10
Market cap
CAD 2.3B
Price
CAD 11.94
Price currency
CAD
Rev Per Employee
326,679.82x
Sector
Healthcare
Sic
2834
Symbol
cse/TRUL
Website
https://www.trulieve.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
-4.93%
EV Earnings
-23.46x
EV/EBIT
12.8x
EV/EBITDA
5.33x
EV/FCF
7.91x
EV/Sales
1.63x
FCF yield
14.62%
Forward P/E
109.03x
P/B ratio
1.43x
P/S ratio
1.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

22
MetricValue
EBIT Margin
12.7%
EBITDA Margin
27.57%
FCF margin
20.55%
Gross margin
59.65%
Gross Profit
CAD 974.4M
Gross Profit Growth
-3.74%
Gross Profit Growth Q
-7.17%
Gross Profit Growth3 Y
1.86%
Gross Profit Growth5 Y
9.24%
Net Income
CAD -113.2M
Net Income Growth Quarters
3%
Net Income Growth Years
2%
Pretax Margin
8.24%
Profit Margin
-6.93%
Profit Per Employee
CAD -22,642
ROA
3.28
Roa5y
3.5
ROCE
5.59
ROE
-6.85
Roe5y
-10.83
ROIC
-8.7
Roic5y
-3.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

15
MetricValue
Cagr1y
97.12%
Cagr3y
15.34%
Cagr5y
-24.82%
EPS Growth Quarters
3
EPS Growth Years
2
FCF Growth
332.92%
FCF Growth Q
24.72%
OCF Growth
51.2%
OCF Growth Q
9.8%
OCF Growth5 Y
15.44%
Revenue Growth
-1.39x
Revenue Growth Q
-3.7x
Revenue Growth Years
2x
Revenue Growth3 Y
-0.64x
Revenue Growth5 Y
13.57x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
CAD 0.41
Assets
CAD 3.9B
Cash
CAD 492.6M
Current Assets
CAD 892.6M
Current Liabilities
CAD 169.7M
Debt
CAD 877.6M
Debt EBITDA
CAD 1.76
Debt Equity
CAD 0.55
Debt FCF
CAD 2.61
Equity
CAD 1.6B
Interest Coverage
2.46
Liabilities
CAD 2.3B
Long Term Assets
CAD 3B
Long Term Liabilities
CAD 2.1B
Net Cash
CAD -385M
Net Cash By Market Cap
CAD -16.77
Net Debt EBITDA
CAD 0.85
Net Debt Equity
CAD 0.24
Net Debt FCF
CAD 1.15
Tangible Book Value
CAD -135.2M
Tangible Book Value Per Share
CAD -0.7
WACC
8.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
5.26
Inventory Turnover
1.96
Net Working Capital
CAD 289.1M
Quick ratio
3.01
Working Capital
CAD 738.1M
Working Capital Turnover
CAD 3.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-0.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
97.03%
200-day SMA
9.9
3Y total return
53.47%
50-day SMA
9.6
50-day SMA vs 200-day SMA
50under200
5Y total return
-75.98%
All Time High
67.45
All Time High Change
-82.3%
All Time High Date
2021-02-10
All Time Low
4.3
All Time Low Change
177.67%
All Time Low Date
2025-04-07
ATR
1
Beta
1.83
Beta1y
1.2
Beta2y
1.45
Ch YTD
0.25
High
12.92
High52
16.35
High52 Date
2025-12-18
High52ch
-26.97%
Low
11.94
Low52
4.45
Low52 Date
2025-06-23
Low52ch
168.32%
Ma50ch
24.36%
Price vs 200-day SMA
20.62%
RSI
55.16
RSI Monthly
52.6
RSI Weekly
58.4
Sharpe ratio
1.07x
Sortino ratio
2.19
Total Return
-0.67%
Tr YTD
0.25
Tr1m
43.34%
Tr1w
-9.06%
Tr3m
25.95%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
CAD 207.5M
Operating Income Growth
79.38
Operating Income Growth Q
0.92
Operating Income Growth3 Y
8.53
Operating Income Growth5 Y
-10.17
Operating margin
12.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
165,861,618%
Net Borrowing
-263,550,835.4
Shares Insiders
5.32%
Shares Institutions
10.62%
Shares Out
192,307,059
Shares Qo Q
3.16%
Shares Yo Y
0.67%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

55
MetricValue
Adjusted FCF
CAD 306.9M
Average Volume
394,290.05x
Bv Per Share
8.47
CAPEX
CAD -51.5M
Ch1m
43.34
Ch1w
-9.06
Ch1y
97.03
Ch3m
25.95
Ch3y
53.47
Ch5y
-75.98
Ch6m
29.08
Change
-5.61%
Change From Open
-6.72
Close
12.65
Days Gap
1.19
Depreciation Amortization
237,801,081.6
Dollar Volume
5,962,979.3
Earnings Date
2026-05-07
EBIT
CAD 207.5M
EBITDA
CAD 450.3M
EPS
CAD -0.59
F Score
5
FCF
CAD 335.7M
FCF EV Yield
12.64x
FCF Per Share
CAD 1.75
Financing CF
-294,766,548
Fiscal Year End
December
Founded
1,940
Goodwill
661,522,330.3
Income Tax
CAD 247.8M
Investing CF
-59,610,201
Is Primary Listing
1
Last Earnings Date
2026-05-07
Last Report Date
2026-03-31
Ma150
9.93
Ma150ch
20.23%
Ma20
11.36
Ma20ch
5.08%
Net CF
32,832,023
Next Earnings Date
2026-08-07
Open
12.8
P FCF Ratio
6.84
P OCF Ratio
5.93
Position In Range
0
Ppne
1,164,689,689.7
Price Date
2026-05-08
Price EBITDA
CAD 5.1
Relative Volume
1.31x
Revenue
1,633,399,080x
SBC By Revenue
1.77x
Share Based Comp
28,838,468
Tax By Revenue
15.17x
Tax Rate
184.2%
Tr6m
29.08%
Volume
499,412
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does CSE/TRUL pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/TRUL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+97.0%
S&P 500 1Y: n/a
3Y total return
+53.5%
S&P 500 3Y: n/a
5Y total return
-76.0%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns CSE/TRUL?

Insider, institutional, and short-interest positioning.

Institutional ownership
+10.6%
Share of float held by funds and institutions
Insider ownership
+5.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.7%
Negative means the company is buying back shares.
Technical

CSE/TRUL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
55.2
Neutral momentum band
Price vs 200-day MA
+20.6%
50/200-day relationship not available
Beta (5Y)
1.83
More volatile than the market
Sharpe ratio
1.07
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About CSE/TRUL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/TRUL stock rating?

cse/TRUL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/TRUL analysis?

The full report lives at /stocks/cse/TRUL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/TRUL?

The latest report frames cse/TRUL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/TRUL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.